MS SC634

Recognizes that African-American men face disproportionately high prostate cancer risk, with one in six developing the disease in their lifetime.

Notes African-American men are 1.7 times more likely to be diagnosed with prostate cancer and 2.3 times more likely to die from it compared to white men.

Acknowledges that early detection offers the best chance for effective treatment, while metastatic progression has poor prognosis with median survival of about three years.

Encourages culturally-competent outreach to educate communities of color about early detection importance and urges African-American men to participate in clinical trials.

Directs clinical trials to actively recruit African-American men to improve representation and outcomes in prostate cancer research.